Published : Oct-2017
No. of Pages : 227
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 10
2 Introduction 11
2.1 Hip Reconstruction Devices Overview 11
3 Products under Development 13
3.1 Hip Reconstruction Devices - Pipeline Products by Stage of Development 13
3.2 Hip Reconstruction Devices - Pipeline Products by Segment 14
3.3 Hip Reconstruction Devices - Pipeline Products by Territory 15
3.4 Hip Reconstruction Devices - Pipeline Products by Regulatory Path 16
3.5 Hip Reconstruction Devices - Pipeline Products by Estimated Approval Date 17
3.6 Hip Reconstruction Devices - Ongoing Clinical Trials 18
4 Hip Reconstruction Devices - Pipeline Products under Development by Companies 19
4.1 Hip Reconstruction Devices Companies - Pipeline Products by Stage of Development 19
4.2 Hip Reconstruction Devices - Pipeline Products by Stage of Development 21
5 Hip Reconstruction Devices Companies and Product Overview 23
5.1 4-Web Spine, LLC Company Overview 23
5.2 Amedica Corp Company Overview 24
5.3 Arthromeda Inc Company Overview 25
5.4 Biotechni SAS Company Overview 26
5.5 Bonovo Orthopedics Inc Company Overview 28
5.6 ConforMIS Inc Company Overview 30
5.7 Corentec Co Ltd Company Overview 31
5.8 DePuy Synthes Inc Company Overview 32
5.9 Exactech Inc Company Overview 38
5.10 Flexable Orthopedics Company Overview 42
5.11 Fortis Orthopedics Company Overview 43
5.12 Fraunhofer Institute for Applied Polymer Research Company Overview 44
5.13 Hip Innovation Technology LLC Company Overview 45
5.14 Implants International Ltd Company Overview 48
5.15 Inor Medical Products Ltd Company Overview 49
5.16 JRI Orthopaedics Ltd Company Overview 51
5.17 KYOCERA Medical Corp Company Overview 64
5.18 Limacorporate SpA Company Overview 65
5.19 Metalicity Ltd Company Overview 67
5.20 MicroPort Scientific Corp Company Overview 68
5.21 MX Orthopedics Corp Company Overview 70
5.22 Nano Interface Technology LLC (Inactive) Company Overview 71
5.23 OrthoGrid Systems Company Overview 72
5.24 PreSRV Ltd. Company Overview 73
5.25 Pro-Dex Inc Company Overview 74
5.26 Renova Orthopedics, LLC Company Overview 75
5.27 Rochester Institute of Technology Company Overview 76
5.28 SINTEF Company Overview 77
5.29 Smith & Nephew Plc Company Overview 78
5.30 Stanford University Company Overview 79
5.31 Stryker Corporation Company Overview 80
5.32 University of Alberta Company Overview 82
5.33 University of Auckland Company Overview 83
5.34 University of South Florida Company Overview 84
5.35 University of Warwick Company Overview 86
5.36 X-NOV Company Overview 88
5.37 Zimmer Biomet Holdings Inc Company Overview 89
6 Hip Reconstruction Devices - Recent Developments 94
6.1 Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director 94
6.2 Aug 31, 2017: Beijing Chunlizhengda Medical Instruments: Interim Results Announcement For The Six Months Ended 30 June 2017 94
6.3 Aug 29, 2017: MicroPort Orthopedics Announces Launch of its Procotyl Prime Acetabular Cup System for Total Hip Replacement Surgery 97
6.4 Aug 23, 2017: Henry Ford Hospital CEO Announces Retirement 97
6.5 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 98
6.6 Aug 11, 2017: Bonovo participated in the Chinese Medical Association of neurosurgery branch of the 16th academic conference 100
6.7 Aug 09, 2017: Hip Innovation Technology Initiates Clinical Trial of its Novel Hip Replacement System for the Treatment of Total Hip Arthroplasty 100
6.8 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 101
6.9 Aug 08, 2017: Materialise Reports Second Quarter 2017 Results 101
6.10 Aug 07, 2017: Orthofix International Reports Second Quarter 2017 Financial Results 104
6.11 Aug 05, 2017: Bonovo participated in the first session of the Great Wall Orthopedic Forum, the 14th Beijing Orthopedic Association (BOA) and the first Beijing - Shanghai Orthopedic Summit meeting 105
6.12 Aug 02, 2017: Wright Medical Group Reports 2017 Second Quarter Financial Results 105
6.13 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 107
6.14 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 108
6.15 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 108
6.16 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 109
6.17 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 110
6.18 Jul 27, 2017: Stryker reports second quarter 2017 results 113
6.19 Jul 27, 2017: Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue 114
6.20 Jul 19, 2017: PathPartner Technology Contributes to Arthromeda's Successful Preclinical Study of Arthrosight-PS Hip Alignment Navigation System 115
6.21 Jul 19, 2017: Mr. Stephen Ooi, Former Zimmer Executive, Newly Appointed as Independent Board Director of XinRong Medical 116
6.22 Jul 18, 2017: Implanet Announces H1 2017 Revenue 116
6.23 Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 117
6.24 Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 118
6.25 Jul 07, 2017: MicroPort OrthoRecon Hosts Hip Replacement Live Surgery Symposium 119
6.26 Jul 06, 2017: Medacta Spine Delivers Strong Growth in Q1 2017 and Introduces Key New Products 119
6.27 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 120
6.28 Jun 26, 2017: Henry Ford Welcomes Three New Senior Executives 120
6.29 Jun 22, 2017: Exactech Expands Presence in Japan with Newly Approved Shoulder, Knee and Hip Replacement Systems 121
6.30 Jun 20, 2017: ConforMIS Announces FDA 510(k) Clearance for iTotal Hip System 122
6.31 Jun 19, 2017: MicroPort OrthoRecon Hosts SuperPath Training Course 122
6.32 Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility 123
6.33 Jun 12, 2017: Alteon HA Femoral Hip Stem Rounds Out Big Week of First Surgeries for Exactech 123
6.34 Jun 08, 2017: Amedica Releases 2016 Preliminary Earnings Report and Business Update 124
6.35 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 126
6.36 Jun 02, 2017: MicroPort OrthoRecon Attends CAOS 2017 126
6.37 May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress 127
6.38 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 128
6.39 May 23, 2017: Brainlab Chief Financial Officer Joseph Doyle to Retire 131
6.40 May 15, 2017: Henry Ford Health System Welcomes New Lansing Based Government Affairs Manager 132
6.41 May 15, 2017: Henry Ford Wyandotte Hospital Welcomes Two Top Leaders 132
6.42 May 09, 2017: Materialise Reports First Quarter 2017 Results 133
6.43 May 08, 2017: Stryker Orthopaedics 2016 Settlement Program reaches milestone 135
6.44 May 05, 2017: Smith & Nephew 2017 First Quarter Trading Report 135
6.45 May 04, 2017: Orthofix International Reports First Quarter 2017 Financial Results 137
6.46 May 03, 2017: Wright Medical Group Reports 2017 First Quarter Financial Results 138
6.47 May 02, 2017: Brainlab Names New Member of Executive Board 140
6.48 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 141
6.49 Apr 25, 2017: Stryker reports first quarter 2017 results 142
6.50 Apr 25, 2017: Exactech Q1 Revenue Up 6% to $69.5 Million on 21% Extremities Growth 143
6.51 Apr 21, 2017: Henry Ford Cancer Institute Appoints Vice President, Executive Director 144
6.52 Apr 19, 2017: Amedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter 144
6.53 Apr 18, 2017: Implanet announces Q1 2017 revenue 145
6.54 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 145
6.55 Apr 03, 2017: Judge Awards $2 Million to Zimmer Hip Implant Plaintiff Represented by Osborne & Associates and McGinn, Carpenter, Montoya & Love 146
6.56 Apr 03, 2017: Generous Foundation Grant to Help Start New Global Technology Development Program at Henry Ford Health System 147
6.57 Mar 31, 2017: B. Braun continues its sales and earnings growth 148
6.58 Mar 31, 2017: Beijing Chunlizhengda Medical: Annual results announcement for the year ended 31 December 2016 149
6.59 Mar 30, 2017: Exactech New Scientific and Clinical Research Presented at 2017 Orthopaedic Research Society Annual Meeting 155
6.60 Mar 29, 2017: OrthAlign Announces Milestone Achievement 60,000th Joint Arthroplasty Case 155
6.61 Mar 28, 2017: Henry Ford Veteran Doctor Kimberly A. Brown to Help Lead Transplant Institute 156
6.62 Mar 24, 2017: Henry Ford Hospital Dermatologist Named Dermatology Chair 157
6.63 Mar 20, 2017: MicroPort OrthoRecon Attends 5th CHS Annual Meeting 157
6.64 Mar 15, 2017: DJO Global Announces FDA 510(K) Clearance for Exprt Revision Hip 158
6.65 Mar 14, 2017: Corin launches Optimized Positioning System (OPS) for hip replacement at AAOS 159
6.66 Mar 14, 2017: Zimmer Biomet Showcases New Product Innovation, Novel Digital Health Offering and Robotic Technology at AAOS 2017 159
6.67 Mar 14, 2017: Medacta Helps Hospitals and Surgeons Go "All In" on Outpatient Care 161
6.68 Mar 13, 2017: OrthoGrid Systems Announces Mark J. Carrico as Director of Marketing 162
6.69 Mar 09, 2017: John Masonis, MD to Educate on Direct Anterior Approach Hip Replacement Using OrthoGrid's HipGrid System at AAOS 2017 Annual Meeting 162
6.70 Mar 07, 2017: Intellijoint Surgical Announces intellijoint HIP Anterior Application FDA Clearance 163
6.71 Mar 06, 2017: MicroPort OrthoRecon Attends 2nd National Academic Conference in Enhanced Recovery After Arthroplasty 163
6.72 Mar 01, 2017: OrthAlign Appoints Eric B. Timko As New Chief Executive Officer and Chairman of the Board 164
6.73 Feb 27, 2017: Amedica Announces Results of Independent Femoral Head Wear Testing 164
6.74 Feb 27, 2017: Orthofix International Reports Fourth Quarter and Fiscal 2016 Financial Results 165
6.75 Feb 22, 2017: Change in the B. Braun Management Board 166
6.76 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 166
6.77 Feb 21, 2017: Wright Medical Group Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 Guidance 169
6.78 Feb 21, 2017: Exactech 2016 Revenue Up 7% to $257.6 Million, Q4'16 Revenue Increased 6% to $66.2 Million 171
6.79 Feb 10, 2017: New Jersey Stryker Hip Lawsuit Plaintiffs Seek Multi-County Designation for LFIT V40 Femoral Head Claims, Bernstein Liebhard Reports 173
6.80 Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results 174
6.81 Feb 09, 2017: Smith & Nephew: Directorate Change 179
6.82 Feb 07, 2017: Henry Ford Health System Names New Chair of Neurology Department 179
6.83 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 180
6.84 Feb 01, 2017: Medacta USA's Spine Division Begins 2017 with Key Appointment, Significant Growth 181
6.85 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 181
6.86 Jan 31, 2017: OrthAlign Continues Impressive Worldwide Growth in 2016, Including Milestone Achievement 56,000th Joint Arthroplasty Case 182
6.87 Jan 26, 2017: Henry Ford Cancer Institute Earns Distinct Level of Accreditation 183
6.88 Jan 25, 2017: OrthAlign Announces FDA Clearance for Direct Anterior Approach HipAlign 184
6.89 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 185
6.90 Jan 18, 2017: Orthofix Announces Resolution of SEC Investigations 186
6.91 Jan 17, 2017: US District Court Rules in Favor of CoorsTek Medical in Ceramic Hip Implant Lawsuit Clearing the Path for CeraSurf-p Ceramic Hip Implants in the US 187
6.92 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 188
6.93 Jan 17, 2017: Corin welcomes Elvio Gramignano 188
6.94 Jan 16, 2017: Implanet Reports 2016 Sales Growth of +18% to 7.8 Million 189
6.95 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 190
6.96 Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew 190
6.97 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 190
6.98 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 192
6.99 Jan 10, 2017: Orthofix Announces Preliminary 2016 Fourth Quarter and Full Year Net Sales Results 192
6.100 Jan 04, 2017: Henry Ford Health System Welcomes New President and CEO 193
6.101 Dec 20, 2016: New England Baptist Hospital Chosen by General Electric as a National Center of Excellence for Hip and Knee Replacement 194
6.102 Dec 19, 2016: Stryker Orthopaedics to compensate additional eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems 194
6.103 Dec 16, 2016: Greatbatch Medical Recalls Standard Offset Cup Impactor Used for Hip Joint Replacement due to Inadequate Sterilization 195
6.104 Dec 14, 2016: National Joint Registry Analysis Finds Zimmer Biomet Trabecular Metal Cups Associated with Significantly Lower Risk of Subsequent Revision Due to Infection in Revision Hip Procedures 196
6.105 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 197
6.106 Dec 13, 2016: Orthofix Announces Appointment of Alex Lukianov to Board of Directors 197
6.107 Dec 09, 2016: Microport Orthopedics has issued a hazard alert for components used for metal-on-metal hip implant components 198
6.108 Dec 07, 2016: Further Far East Contract Success For JRI Orthopaedics 198
6.109 Dec 05, 2016: KYOCERA Medical Receives FDA 510(k) Clearance for Initia Total Hip System, Featuring BIOCERAM AZUL Ceramic Femoral Head 199
6.110 Dec 01, 2016: Dallas Jury Returns $1 Billion-Plus Verdict in Defective DePuy Hip Implants Lawsuit 199
6.111 Nov 30, 2016: Graham Baker appointed Chief Financial Officer 200
6.112 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 201
6.113 Nov 22, 2016: Amedica appoints vice president of sales and marketing 204
6.114 Nov 22, 2016: Amedica Announces New Sales Leadership and Provides Regulatory Updates 204
6.115 Nov 17, 2016: New UK Business Manager Appointed At JRI Orthopaedics 205
6.116 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 206
6.117 Nov 15, 2016: Henry Ford Radiation Oncology Receives 3-Year ACR Accreditation 206
6.118 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 207
6.119 Nov 14, 2016: First-ever functional, patient-specific hip replacement procedures performed in the USA 207
6.120 Nov 10, 2016: Amedica Reports Third Quarter 2016 Financial Results 208
6.121 Nov 09, 2016: Materialise Reports Third Quarter 2016 Results 209
6.122 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report 212
6.123 Nov 02, 2016: Wright Medical Group Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance 213
6.124 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 215
6.125 Oct 31, 2016: Exactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20. 216
6.126 Oct 31, 2016: Orthofix International Reports Third Quarter 2016 Financial Results 217
6.127 Oct 27, 2016: Stryker reports third quarter 2016 results 219
6.128 Oct 10, 2016: Northgate Public Services secures five year contract extension with the National Joint Registry 220
6.129 Oct 10, 2016: Implanet Announces Q3 2016 Sales of 1.5 Million 221
6.130 Oct 06, 2016: Amedica Provides Business Update 222
6.131 Oct 05, 2016: Henry Ford Health System Announces New CEO of Health Alliance Plan 223
6.132 Oct 05, 2016: Amedica Announces Workforce Reduction 223
7 Appendix 224
7.1 Methodology 224
7.2 About GlobalData 227
7.3 Contact Us 227
7.4 Disclaimer 227
1.1 List of Tables
Table 1: Hip Reconstruction Devices - Pipeline Products by Stage of Development 13
Table 2: Hip Reconstruction Devices - Pipeline Products by Segment 14
Table 3: Hip Reconstruction Devices - Pipeline Products by Territory 15
Table 4: Hip Reconstruction Devices - Pipeline Products by Regulatory Path 16
Table 5: Hip Reconstruction Devices - Pipeline Products by Estimated Approval Date 17
Table 6: Hip Reconstruction Devices - Ongoing Clinical Trials 18
Table 7: Hip Reconstruction Devices Companies - Pipeline Products by Stage of Development 19
Table 8: Hip Reconstruction Devices - Pipeline Products by Stage of Development 21
Table 9: 4-Web Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 23
Table 10: Truss Implant - Hip Procedures - Product Status 23
Table 11: Truss Implant - Hip Procedures - Product Description 23
Table 12: Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview 24
Table 13: Infinia Total Hip Implant II - Product Status 24
Table 14: Infinia Total Hip Implant II - Product Description 24
Table 15: Arthromeda Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 16: ArthroSight-PS - Product Status 25
Table 17: ArthroSight-PS - Product Description 25
Table 18: Biotechni SAS Pipeline Products & Ongoing Clinical Trials Overview 26
Table 19: MULTI-T64 - Product Status 26
Table 20: MULTI-T64 - Product Description 26
Table 21: MULTI-T66 - Product Status 27
Table 22: MULTI-T66 - Product Description 27
Table 23: Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 24: JMM Total Hip System - Product Status 28
Table 25: JMM Total Hip System - Product Description 28
Table 26: Konknow Hip System - Product Status 29
Table 27: Konknow Hip System - Product Description 29
Table 28: ConforMIS Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 29: iTotal Hip System - Product Status 30
Table 30: iTotal Hip System - Product Description 30
Table 31: Corentec Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 31
Table 32: Bencox ID Cemented Stem - Collarless - Product Status 31
Table 33: Bencox ID Cemented Stem - Collarless - Product Description 31
Table 34: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 35: Bone Preserving Hip Stem - Product Status 32
Table 36: Bone Preserving Hip Stem - Product Description 32
Table 37: DeltaMotion Hip System - Product Status 33
Table 38: DeltaMotion Hip System - Product Description 33
Table 39: Hip Resurfacing System - Product Status 33
Table 40: Hip Resurfacing System - Product Description 34
Table 41: New Poly Hip Bearing - Product Status 34
Table 42: New Poly Hip Bearing - Product Description 34
Table 43: Next Generation Hip System - Product Status 34
Table 44: Next Generation Hip System - Product Description 35
Table 45: DePuy Synthes Inc - Ongoing Clinical Trials Overview 36
Table 46: DeltaMotion Hip System - A Multi-center, Prospective, Uncontrolled Post Market Clinical Follow-up Study (PMCFS) to Monitor the Survival and Performance of the DeltaMotion Cup System in Subjects Requiring a Total Hip Replacement 37
Table 47: DeltaMotion Hip System - RSA-Measured in Vivo Migration and Micromotion in the DePuy Tri-lock, Corail and Deltamotion Hip Replacement Components: A Single-blinded Randomised Control Trial 37
Table 48: Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 49: Alteon Acetabular System - Product Status 38
Table 50: Alteon Acetabular System - Product Description 38
Table 51: Alteon HA System - Product Status 39
Table 52: Alteon HA System - Product Description 39
Table 53: Alteon Revision Modular System - Product Status 39
Table 54: Alteon Revision Modular System - Product Description 39
Table 55: Exactech GPS Hip System - Product Status 40
Table 56: Exactech GPS Hip System - Product Description 40
Table 57: Hip Revision System - Product Status 40
Table 58: Hip Revision System - Product Description 40
Table 59: HIP Wedge Stem - Product Status 41
Table 60: HIP Wedge Stem - Product Description 41
Table 61: Flexable Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 42
Table 62: Flex-Able - Product Status 42
Table 63: Flex-Able - Product Description 42
Table 64: Fortis Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 43
Table 65: MiHip System - Product Status 43
Table 66: MiHip System - Product Description 43
Table 67: Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview 44
Table 68: Enhanced Durability Resurfacing Endoprosthesis - Product Status 44
Table 69: Enhanced Durability Resurfacing Endoprosthesis - Product Description 44
Table 70: Hip Innovation Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 45
Table 71: HIT Hip Replacement System - Product Status 45
Table 72: HIT Hip Replacement System - Product Description 45
Table 73: Hip Innovation Technology LLC - Ongoing Clinical Trials Overview 46
Table 74: HIT Hip Replacement System - A Multi-center Prospective Study of the Hip Innovation Technology (HIT) Hip Replacement System in Primary Total Hip Arthroplasty 47
Table 75: Implants International Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
Table 76: Phoenix Re-Surf - Product Status 48
Table 77: Phoenix Re-Surf - Product Description 48
Table 78: Inor Medical Products Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
Table 79: INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK - Product Status 49
Table 80: INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK - Product Description 49
Table 81: INOR TOTAL HIP SYSTEM Stainless Steel XL Series-Long Neck - Product Status 50
Table 82: INOR TOTAL HIP SYSTEM Stainless Steel XL Series-Long Neck - Product Description 50
Table 83: JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
Table 84: Acetabular Cup Liner - Product Status 51
Table 85: Acetabular Cup Liner - Product Description 52
Table 86: Avanteon Hip System - Product Status 52
Table 87: Avanteon Hip System - Product Description 52
Table 88: Ceramic Femoral Head - Product Status 53
Table 89: Ceramic Femoral Head - Product Description 53
Table 90: Furlong Evolution - Product Status 53
Table 91: Furlong Evolution - Product Description 54
Table 92: Furlong H-A.C. Acetabular Cup - Product Status 54
Table 93: Furlong H-A.C. Acetabular Cup - Product Description 55
Table 94: Furlong H-A.C. Hemi-Arthroplasty System - Product Status 55
Table 95: Furlong H-A.C. Hemi-Arthroplasty System - Product Description 56
Table 96: Furlong H-A.C. Revision Hip Stem - Product Status 56
Table 97: Furlong H-A.C. Revision Hip Stem - Product Description 57
Table 98: Furlong H-A.C. THR System - Product Status 57
Table 99: Furlong H-A.C. THR System - Product Description 58
Table 100: Furlong Hemi-Arthroplasty System - Product Status 58
Table 101: Furlong Hemi-Arthroplasty System - Product Description 59
Table 102: Furlong Modular THR - Product Status 59
Table 103: Furlong Modular THR - Product Description 59
Table 104: Furlong Securus Femoral Revision System - Product Status 60
Table 105: Furlong Securus Femoral Revision System - Product Description 60
Table 106: JRI Orthopaedics Ltd - Ongoing Clinical Trials Overview 61
Table 107: Furlong Evolution - A Prospective Multicentre Clinical Surveillance Study to Evaluate The Stability, Efficacy and Safety of the Furlong Evolution Hip Stem in Primary Total Hip Arthroplasty 62
Table 108: Furlong Evolution - Ceramic-on-ceramic Bearings In Hip Replacement With Low Rates Of Wear And Are Increasingly Being Used In Young Adults 62
Table 109: Furlong Evolution - Evaluation of a Short Femoral Stem in Total Hip Arthroplasty. A Comparative Study on Stability, Bone Remodelling and Patient Outcome 62
Table 110: Avanteon Hip System - Prospective, Open Label, Single Arm, Monocentric Clinical Study Intended to Observe Efficacy and Safety of the Aeon-shaft (Artificial Hip Joint), Fa. Brehm, in Patients with Osteoarthritis of the Hip or a Fracture of the Femoral Neck 63
Table 111: KYOCERA Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 64
Table 112: Aquala Liner - Product Status 64
Table 113: Aquala Liner - Product Description 64
Table 114: Limacorporate SpA Pipeline Products & Ongoing Clinical Trials Overview 65
Table 115: DELTA-ONE-TT - Product Status 65
Table 116: DELTA-ONE-TT - Product Description 65
Table 117: DELTA-Revision TT - Product Status 66
Table 118: DELTA-Revision TT - Product Description 66
Table 119: Metalicity Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
Table 120: M-COR Primary Press-Fit - Product Status 67
Table 121: M-COR Primary Press-Fit - Product Description 67
Table 122: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 68
Table 123: Anterior Approach THA Instrument - Product Status 68
Table 124: Anterior Approach THA Instrument - Product Description 68
Table 125: Next Generation Optimized ML Taper Hip Stem - Product Status 69
Table 126: Next Generation Optimized ML Taper Hip Stem - Product Description 69
Table 127: XL & E-POLY BIOFOAM - Product Status 69
Table 128: XL & E-POLY BIOFOAM - Product Description 69
Table 129: MX Orthopedics Corp Pipeline Products & Ongoing Clinical Trials Overview 70
Table 130: Shape Memory Alloy Hip Implant - Product Status 70
Table 131: Shape Memory Alloy Hip Implant - Product Description 70
Table 132: Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71
Table 133: Hip Implant - Product Status 71
Table 134: Hip Implant - Product Description 71
Table 135: OrthoGrid Systems Pipeline Products & Ongoing Clinical Trials Overview 72
Table 136: HipFXGrid - Product Status 72
Table 137: HipFXGrid - Product Description 72
Table 138: PreSRV Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
Table 139: Atlas Femoral Head Preserving Prosthesis - Product Status 73
Table 140: Atlas Femoral Head Preserving Prosthesis - Product Description 73
Table 141: Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview 74
Table 142: Acetabular Cup Revision Tool - Product Status 74
Table 143: Acetabular Cup Revision Tool - Product Description 74
Table 144: Renova Orthopedics, LLC Pipeline Products & Ongoing Clinical Trials Overview 75
Table 145: A-FX Hip Fracture System - Product Status 75
Table 146: A-FX Hip Fracture System - Product Description 75
Table 147: Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 76
Table 148: Artificial Hip Joint - Product Status 76
Table 149: Artificial Hip Joint - Product Description 76
Table 150: SINTEF Pipeline Products & Ongoing Clinical Trials Overview 77
Table 151: Smart Hip Prosthesis - Product Status 77
Table 152: Smart Hip Prosthesis - Product Description 77
Table 153: Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 78
Table 154: Navio Total Hip Arthroplasty System - Product Status 78
Table 155: Navio Total Hip Arthroplasty System - Product Description 78
Table 156: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 79
Table 157: Avascular Necrosis Implant - Product Status 79
Table 158: Avascular Necrosis Implant - Product Description 79
Table 159: Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 80
Table 160: Hip Distraction Device - Product Status 80
Table 161: Hip Distraction Device - Product Description 80
Table 162: MITCH TRH System - Product Status 81
Table 163: MITCH TRH System - Product Description 81
Table 164: University of Alberta Pipeline Products & Ongoing Clinical Trials Overview 82
Table 165: Hip Replacement And Bone Loss Monitor - Product Status 82
Table 166: Hip Replacement And Bone Loss Monitor - Product Description 82
Table 167: University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 83
Table 168: Acetabular Reconstruction Implant - Product Status 83
Table 169: Acetabular Reconstruction Implant - Product Description 83
Table 170: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 84
Table 171: Cannulated Screw Jig - Product Status 84
Table 172: Cannulated Screw Jig - Product Description 84
Table 173: Injectable Hip Hemiarthroplasty Device - Product Status 85
Table 174: Injectable Hip Hemiarthroplasty Device - Product Description 85
Table 175: University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 86
Table 176: Femoral Head Positioning Device - Product Status 86
Table 177: Femoral Head Positioning Device - Product Description 86
Table 178: Hip Prostheses - Product Status 87
Table 179: Hip Prostheses - Product Description 87
Table 180: X-NOV Pipeline Products & Ongoing Clinical Trials Overview 88
Table 181: Mobipop - Product Status 88
Table 182: Mobipop - Product Description 88
Table 183: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 89
Table 184: Durom Full Resurfacing Hip - Product Status 89
Table 185: Durom Full Resurfacing Hip - Product Description 90
Table 186: E1 Avantage Hip Cup - Product Status 90
Table 187: E1 Avantage Hip Cup - Product Description 90
Table 188: ReCap Total Hip Resurfacing System - Product Status 91
Table 189: ReCap Total Hip Resurfacing System - Product Description 91
Table 190: Zimmer Biomet Holdings Inc - Ongoing Clinical Trials Overview 92
Table 191: E1 Avantage Hip Cup - Evaluation of Cemented and Cementless Fixation of Dual-mobility Hip Prosthesis in Elderly Patients With Osteoarthritis 93
Table 192: E1 Avantage Hip Cup - RCT of the Sirius Stem Used in Conjunction with the Exceed ABT Cemented Cup and OptiPac/OptiVac Cement - Model Based RSA, Clinical and Radiographic Outcomes 93
Table 193: Glossary 226
1.2 List of Figures
Figure 1: Hip Reconstruction Devices - Pipeline Products by Stage of Development 13
Figure 2: Hip Reconstruction Devices - Pipeline Products by Segment 14
Figure 3: Hip Reconstruction Devices - Pipeline Products by Territory 15
Figure 4: Hip Reconstruction Devices - Pipeline Products by Regulatory Path 16
Figure 5: Hip Reconstruction Devices - Pipeline Products by Estimated Approval Date 17
Figure 6: Hip Reconstruction Devices - Ongoing Clinical Trials 18
